Issue 40, 2018

Iron oxide nanoparticles for targeted imaging of liver tumors with ultralow hepatotoxicity

Abstract

Even though iron oxide (Fe3O4) nanoparticles are promising materials for magnetic resonance imaging (MRI) contrast agents, their biocompatibility and targeting efficacy still need to be improved. Herein, we modified glycyrrhetinic acid (GA) groups on Fe3O4 nanoparticles (Fe3O4@cGlu-GA) for liver tumor-targeted imaging. To evaluate the biocompatibility of these nanoparticles, we studied their cytotoxicity, hemolysis, and hepatotoxicity. We measured the uptake of Fe3O4@cGlu-GA nanoparticles in normal and liver tumor cells, then we investigated the specificity of Fe3O4@cGlu-GA nanoparticles in mouse models bearing subcutaneous and orthotopic liver tumors. With good biocompatibility and targeting efficacy both in vitro and in vivo, the Fe3O4@cGlu-GA nanoparticles are promising MRI contrast agents with ultralow hepatotoxicity and show great improvement on existing Fe3O4-based nanoparticles.

Graphical abstract: Iron oxide nanoparticles for targeted imaging of liver tumors with ultralow hepatotoxicity

Supplementary files

Article information

Article type
Paper
Submitted
24 Jūn. 2018
Accepted
03 Sept. 2018
First published
06 Sept. 2018

J. Mater. Chem. B, 2018,6, 6413-6423

Iron oxide nanoparticles for targeted imaging of liver tumors with ultralow hepatotoxicity

J. Li, R. Cha, Y. Zhang, H. Guo, K. Long, P. Gao, X. Wang, F. Zhou and X. Jiang, J. Mater. Chem. B, 2018, 6, 6413 DOI: 10.1039/C8TB01657G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements